Market Outlook:
The India Pneumococcal Vaccine Market, valued at USD 32.52 million in 2024, is poised for robust growth in the coming years. Expected to reach USD 48.67 million by 2030, this market is anticipated to grow at a compound annual growth rate (CAGR) of 6.91% during the forecast period. This growth is driven by factors such as increasing government initiatives for immunization, rising awareness of pneumonia-related health issues, and improving healthcare infrastructure. The demand for p